Selena Simmons-Duffin

Thank you.

Thank you.

Thank you.

Well, it's challenging the Food and Drug Administration's rules about mifepristone, which is one of the pills used for medication abortion. It's also used to manage miscarriages. And if you're thinking, didn't the Supreme Court already reject that case? You would be right, kind of. The justices last year rejected the original challenge brought by a group of Christian doctors.

Well, it's challenging the Food and Drug Administration's rules about mifepristone, which is one of the pills used for medication abortion. It's also used to manage miscarriages. And if you're thinking, didn't the Supreme Court already reject that case? You would be right, kind of. The justices last year rejected the original challenge brought by a group of Christian doctors.

Well, it's challenging the Food and Drug Administration's rules about mifepristone, which is one of the pills used for medication abortion. It's also used to manage miscarriages. And if you're thinking, didn't the Supreme Court already reject that case? You would be right, kind of. The justices last year rejected the original challenge brought by a group of Christian doctors.

But now three states, Missouri, Idaho, and Kansas, have intervened. They're arguing essentially they can't ban abortion if residents can receive this medication through the mail. So they're taking up this challenge to FDA's decisions about medication abortion again.

But now three states, Missouri, Idaho, and Kansas, have intervened. They're arguing essentially they can't ban abortion if residents can receive this medication through the mail. So they're taking up this challenge to FDA's decisions about medication abortion again.

But now three states, Missouri, Idaho, and Kansas, have intervened. They're arguing essentially they can't ban abortion if residents can receive this medication through the mail. So they're taking up this challenge to FDA's decisions about medication abortion again.

Yeah, exactly. They took that position in a filing on Monday. And this was a bit surprising because that's the same position the Biden administration's Justice Department had made. And you might not expect a lot of continuity when it comes to abortion between these two administrations.

Yeah, exactly. They took that position in a filing on Monday. And this was a bit surprising because that's the same position the Biden administration's Justice Department had made. And you might not expect a lot of continuity when it comes to abortion between these two administrations.

Yeah, exactly. They took that position in a filing on Monday. And this was a bit surprising because that's the same position the Biden administration's Justice Department had made. And you might not expect a lot of continuity when it comes to abortion between these two administrations.

Yeah, I don't think that's necessarily what it means. That's in part because the federal judge in Texas who's presiding, Judge Matthew Kesmarek, is known to be very receptive to anti-abortion arguments. So this case might continue regardless of what the Trump administration wants to do.

Yeah, I don't think that's necessarily what it means. That's in part because the federal judge in Texas who's presiding, Judge Matthew Kesmarek, is known to be very receptive to anti-abortion arguments. So this case might continue regardless of what the Trump administration wants to do.

Yeah, I don't think that's necessarily what it means. That's in part because the federal judge in Texas who's presiding, Judge Matthew Kesmarek, is known to be very receptive to anti-abortion arguments. So this case might continue regardless of what the Trump administration wants to do.

Also, this is not the only tool in the Trump administration's toolbox when it comes to restricting abortion cases. Katie Keith is the director of the Georgetown Center for Health Policy and the Law and formerly served on Biden's Gender Policy Council. I would say the jury is still out, essentially, of how aggressive the Trump administration is going to be on medication abortion.

Also, this is not the only tool in the Trump administration's toolbox when it comes to restricting abortion cases. Katie Keith is the director of the Georgetown Center for Health Policy and the Law and formerly served on Biden's Gender Policy Council. I would say the jury is still out, essentially, of how aggressive the Trump administration is going to be on medication abortion.

Also, this is not the only tool in the Trump administration's toolbox when it comes to restricting abortion cases. Katie Keith is the director of the Georgetown Center for Health Policy and the Law and formerly served on Biden's Gender Policy Council. I would say the jury is still out, essentially, of how aggressive the Trump administration is going to be on medication abortion.

She says if they want to restrict access, they could. For example, the Trump administration's FDA could just go ahead and add restrictions on who can get this medication and how without being required to by the court.

She says if they want to restrict access, they could. For example, the Trump administration's FDA could just go ahead and add restrictions on who can get this medication and how without being required to by the court.